Recent progress and new perspectives in lymphoma glycobiology.

Glycosylation has recently become one of the most significant subjects in tumor biology, and cell surface glycosylation is closely associated with various biological phenomena in tumor cells. However, the biological significance of cell surface glycosylation and sialic acid linked to glycans in human malignant lymphoma is not well elucidated. We have determined that 1) sialylation or loss of N-glycosylation is closely associated with a worse prognosis in human diffuse large B-cell lymphoma (DLBCL), and 2) glycosylation or sialic acid on the surface of lymphoma cells plays significant roles in cell adhesion or invasion to the extracellular matrix, cell growth, apoptosis and cell death. In the present review, the biological functions of glycosylation or sialic acid in human malignant lymphoma are discussed.

[1]  H. Stein,et al.  Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells , 2012, Laboratory Investigation.

[2]  A. Ingle,et al.  Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen–Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3 , 2009, Glycoconjugate Journal.

[3]  L. Pinter-Brown.  SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies , 2008 .

[4]  D. Neuberg,et al.  AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features , 2008, Clinical Cancer Research.

[5]  O. Suzuki,et al.  Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma. , 2008, Oncology reports.

[6]  S. Monti,et al.  The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma , 2007, Proceedings of the National Academy of Sciences.

[7]  F. Goñi,et al.  Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. , 2006, Biochimica et biophysica acta.

[8]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[9]  M. Abe,et al.  Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma. , 2005, International journal of oncology.

[10]  S. Stowell,et al.  Dimeric Galectin-1 Binds with High Affinity to α2,3-Sialylated and Non-sialylated Terminal N-Acetyllactosamine Units on Surface-bound Extended Glycans* , 2005, Journal of Biological Chemistry.

[11]  A. Al-Shamkhani.  The role of CD30 in the pathogenesis of haematopoietic malignancies. , 2004, Current opinion in pharmacology.

[12]  R. Schauer.  Sialic acids: fascinating sugars in higher animals and man. , 2004, Zoology.

[13]  N. Taniguchi,et al.  Expression of N-Acetylglucosaminyltransferase V Is Associated with Prognosis and Histology in Non-Small Cell Lung Cancers , 2004, Clinical Cancer Research.

[14]  M. Teitell,et al.  An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. , 2004, The American journal of pathology.

[15]  L. Baum,et al.  Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death* , 2004, Journal of Biological Chemistry.

[16]  T. Yoshii,et al.  CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. , 2003, Cancer research.

[17]  O. Suzuki,et al.  Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-acetylglucosaminyltransferase V in human diffuse large B cell lymphoma. , 2003, Oncology reports.

[18]  O. Suzuki,et al.  Sialic acids linked to glycoconjugates of Fas regulate the caspase-9-dependent and mitochondria-mediated pathway of Fas-induced apoptosis in Jurkat T cell lymphoma. , 2003, International journal of oncology.

[19]  L. Baum,et al.  The ST6Gal I Sialyltransferase Selectively ModifiesN-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death* , 2003, The Journal of Biological Chemistry.

[20]  G. Rabinovich,et al.  Role of galectins in inflammatory and immunomodulatory processes. , 2002, Biochimica et biophysica acta.

[21]  R. Finley,et al.  Galectin-3 Translocates to the Perinuclear Membranes and Inhibits Cytochrome c Release from the Mitochondria , 2002, The Journal of Biological Chemistry.

[22]  O. Suzuki,et al.  UDP-GlcNAc2-epimerase regulates cell surface sialylation and cell adhesion to extracellular matrix in Burkitt's lymphoma. , 2002, International journal of oncology.

[23]  F. Goñi,et al.  Membrane Restructuring via Ceramide Results in Enhanced Solute Efflux* , 2002, The Journal of Biological Chemistry.

[24]  K. Knobeloch,et al.  Sialylation is essential for early development in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Meijer,et al.  MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. , 2001, Journal of clinical pathology.

[26]  L. Baum,et al.  CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans1 , 2001, The Journal of Immunology.

[27]  P. Lance,et al.  Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. , 2001, Biochimica et biophysica acta.

[28]  V. Gouyer,et al.  Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern. , 2001, Journal of cell science.

[29]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[30]  J. Marth,et al.  Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Santini,et al.  β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin , 2000, International journal of cancer.

[32]  赤埴 詩朗.  Galectin-3 : a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family , 2000 .

[33]  S. Spiegel,et al.  Involvement of Sphingosine in Mitochondria-dependent Fas-induced Apoptosis of Type II Jurkat T Cells* , 2000, The Journal of Biological Chemistry.

[34]  Qiong Zhang,et al.  Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells , 2000, Journal of Cancer Research and Clinical Oncology.

[35]  F. Poirier,et al.  Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. , 2000, Glycobiology.

[36]  O. Suzuki,et al.  Phaseolus vulgaris leukoagglutinating lectin‐binding reactivity in human diffuse large B‐cell lymphoma and its relevance to the patient’s clinical outcome: Lectin histochemistry and lectin blot analysis , 1999, Pathology international.

[37]  P. Stewart,et al.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.

[38]  M. Yao,et al.  N-acetylglucosaminyltransferase V activity in metastatic models of human hepatocellular carcinoma in nude mice. , 1999, Journal of experimental & clinical cancer research : CR.

[39]  Jürgen Bajorath,et al.  Analysis of Fas–ligand interactions using a molecular model of the receptor–ligand interface , 1999, J. Comput. Aided Mol. Des..

[40]  M. Peter,et al.  Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. , 1999, Glycobiology.

[41]  M. Pawlita,et al.  UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. , 1999, Science.

[42]  F. Real,et al.  Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. , 1998, The Biochemical journal.

[43]  S. Han,et al.  Apoptotic signal of Fas is not mediated by ceramide. , 1998, Blood.

[44]  J. Marth,et al.  Immune regulation by the ST6Gal sialyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[46]  J. Foidart,et al.  Expression of Lamp‐1 and Lamp‐2 and their interactions with galectin‐3 in human tumor cells , 1998, International journal of cancer.

[47]  S. Kelm,et al.  Sialic Acids in Molecular and Cellular Interactions , 1997, International Review of Cytology.

[48]  R. Aebersold,et al.  Fas-induced apoptosis of T cells occurs independently of ceramide generation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Sillence,et al.  Evidence against an early signalling role for ceramide in Fas-mediated apoptosis. , 1997, The Biochemical journal.

[50]  K. Tasaki,et al.  Analysis of lectin binding properties on human Burkitt's lymphoma cell lines that show high spontaneous metastasis to distant organs in SCID mice: The binding sites for soybean agglutinin lectin masked by sialylation are closely associated with metastatic lymphoma cells , 1996, Pathology international.

[51]  A. Anel,et al.  CPP32 inhibition prevents Fas‐induced ceramide generation and apoptosis in human cells , 1996, FEBS letters.

[52]  H. Gross,et al.  Ecto-sialyltransferase of human B lymphocytes reconstitutes differentiation markers in the presence of exogenous CMP-N-acetyl neuraminic acid. , 1996, Blood.

[53]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[54]  M. Peter,et al.  Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. , 1995, Cell death and differentiation.

[55]  I. Andó,et al.  Effect of phytohaemagglutinin on CD45 in T cells. , 1994, Immunology letters.

[56]  J. Dennis,et al.  Sialylation and malignant potential in tumour cell glycosylation mutants. , 1994, Glycobiology.

[57]  S. Hakomori,et al.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.

[58]  Richard D. Cummings,et al.  Galectins: A family of animal β-galactoside-binding lectins , 1994, Cell.

[59]  N. Hayashi,et al.  N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. , 1993, Cancer research.

[60]  R. Bernacki,et al.  Galaptin-mediated adhesion of human ovarian carcinoma A121 cells and detection of cellular galaptin-binding glycoproteins. , 1993, Cancer research.

[61]  G. Freeman,et al.  The HB-6, CDw75, and CD76 differentiation antigens are unique cell- surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase , 1992, The Journal of cell biology.

[62]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[63]  J. Dennis,et al.  Glycosylation-dependent collagen-binding activities of two membrane glycoproteins in MDAY-D2 tumor cells. , 1988, Cancer research.

[64]  G. Hart,et al.  Cell surface sialic acid influences tumor cell recognition in the mixed lymphocyte reaction. , 1987, Journal of immunology.

[65]  R. Kerbel,et al.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.

[66]  J. Dennis,et al.  Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. , 1983, Cancer research.

[67]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[68]  J. Dennis,et al.  Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin , 1982, Nature.

[69]  C. Buck,et al.  Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[70]  L. Pinter-Brown.  SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies. , 2008, Expert opinion on investigational drugs.

[71]  K. Tasaki,et al.  UDP-GlcNAc2-epimerase regulates cell surface sialylation and ceramide-induced cell death in human malignant lymphoma. , 2008, International journal of molecular medicine.

[72]  O. Suzuki,et al.  The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1. , 2006, International journal of oncology.

[73]  T. Yoshii,et al.  CD 29 and CD 7 Mediate Galectin-3-Induced Type II T-Cell Apoptosis , 2003 .

[74]  G. Freeman,et al.  The HB-6 , CDw 75 , and CD 76 Differentiation Antigens are Unique Cell-Surface Carbohydrate Determinants Generated by the ß-Galactoside a 2 , 6-Sialyltransferase , 2002 .

[75]  J. Ewing,et al.  Murine B cell differentiation is accompanied by programmed expression of multiple novel β-galactoside α2,6-sialyltransferase mRNA forms , 2000 .

[76]  P. Schlag,et al.  Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens. , 1998, Cancer detection and prevention.

[77]  K. Konstantinov,et al.  Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. , 1996, The American journal of pathology.

[78]  S. Barondes,et al.  Galectins: a family of animal beta-galactoside-binding lectins. , 1994, Cell.